98%
921
2 minutes
20
During the COVID-19 pandemic, vaccination rates among pregnant women were notably lower due to concerns about vaccine safety and effectiveness. We investigated the impact of COVID-19 vaccination on hospitalization and illness severity due to COVID-19 among pregnant women. Data were obtained from the Korea Disease Control and Prevention Agency's COVID-19 National Health Insurance Service cohort, including 2,235 pregnant women and 6,733 nonpregnant women (1:3 matched) infected with COVID-19 between October 2020 and December 2021. COVID-19 vaccination status was categorized as unvaccinated, first dose only, and fully vaccinated (2 or more doses). Logistic regression was performed to identify factors associated with hospitalization and illness severity. Among pregnant women infected with COVID-19, 88.4% were unvaccinated, 4.6% received 1 dose, and 7.1% were fully vaccinated, compared to 61.3%, 8.1%, and 30.6%, respectively, for nonpregnant women. The odds ratio (OR) for hospitalization was significantly higher for pregnant women compared to nonpregnant women (OR=1.78). Within the pregnant women cohort, the OR for hospitalization was 0.92 for those who received the first vaccine dose and 0.37 for those who were fully vaccinated, demonstrating a significantly lower hospitalization rate only in the fully vaccinated group. A similar pattern was observed for illness severity, with ORs of 0.74 for the first dose and 0.33 for full vaccination, indicating a significantly lower rate of severe illness only in the fully vaccinated group. Additionally, high-risk pregnant women exhibited significantly higher odds of both hospitalization and severe illness. These findings demonstrate that full COVID-19 vaccination coverage (2 or more doses) is strongly associated with decreased hospitalization and severe illness among pregnant women. Addressing vaccine hesitancy through prenatal care discussions and improving vaccine accessibility is essential to enhance maternal health outcomes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/hs.2024.0141 | DOI Listing |
Aging Cell
September 2025
Division of Biomedical and Life Sciences, Lancaster University, Lancaster, UK.
Almost half of pregnant women globally are currently estimated to be overweight or obese. Rates of childhood obesity are also on the rise, in part because of increased consumption of dietary saturated fats. However, the long-term effect of peri- and postnatal high fat (HF) feeding on cognitive function and neuronal expression has not yet been investigated.
View Article and Find Full Text PDFActa Trop
September 2025
Department of Public Health, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium.
Congenital toxoplasmosis (CT) due to Toxoplasma gondii, an apicomplexan parasite, leads to significant sequelae in children, foetal losses and neonatal deaths worldwide. This study aimed to assess the burden of CT in Burundi for the year 2020. We used epidemiological and economic data collected in major hospitals in Burundi, the Ministry of Public Health in Burundi and international peer-reviewed literature to estimate the disability-adjusted life years (DALYs) and economic costs spent on prenatal consultations, diagnosis and treatment of toxoplasmosis for pregnant women.
View Article and Find Full Text PDFBrain Res
September 2025
Programa de Pós-Graduação em Neurociências, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil; Departamento de Ciências Morfológicas, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre,
It has been recently described the Congenital Zika Syndrome (CZS). Children from pregnant women who were infected by the virus have expressed a set of symptoms, particularly involving neurological disorders such as microcephaly. Animal models have been conducted aiming to enhance the knowledge about the CZS and giving support for future studies proposing prevention and treatment for this condition.
View Article and Find Full Text PDFInt J Infect Dis
September 2025
University of San Francisco, Department of Nursing and Health Professions, San Francisco, California, United States; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Epidemiology, Fielding School of Public Health, University of California, Los A
Objectives: To quantify the incidence of adverse events given COVID-19 vaccination and COVID-19 diagnosis in women of reproductive age; to examine pregnancy as a potential risk modifier.
Methods: An exposure-matched cohort study of >1 million women, 11 December 2020-30 September 2022, United States. COVID-19 vaccination, COVID-19 diagnoses, and medically-attended adverse events - including immunologic, neurologic, cerebrovascular, thromboembolic, cardiovascular, respiratory, thrombocytopenic and coagulative events - were identified from inpatient and outpatient medical claims.